The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with mosquito-borne malaria.

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally, and children are the most badly affected.

The 10.3% of participants that experienced recrudescence -- recurrent malaria caused by the same strain of P. falciparum as the initial infection after treatment with artesunate followed by artemether-lumefantrine combination therapy -- was also notable John told MedPage Today.

An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives — the primary treatment for malaria — in young children with severe malaria.

A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children with severe forms of the parasitic disease.

Every year around 600,000 people all over the world die from mosquito-borne malaria, among which majority are children under 5.Now, a disturbing news has emerged that the parasite responsible for the Malaria appears to be developing resistance